Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Prostate cancer surgery: could it become a Same-Day procedure?

NCT ID NCT06891664

Symptom relief Sponsor: Regina Elena Cancer Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether men with prostate cancer can have robotic surgery to remove the prostate and go home the same day, instead of staying in the hospital overnight. Researchers will check how many patients agree to try this approach and how well it works. The goal is to see if day surgery is safe and improves quality of life while lowering healthcare costs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients with localized prostate adenocarcinoma at low-intermediate risk (EAU Risk classification); * patients aged \>= 18 years; * patients with an indication to undergo robotic radical prostatectomy without lymphadenectomy according to the EAU guidelines; * patients who agree to undergo robotic radical prostatectomy without lymphadenectomy according to the EAU guidelines by signing a written informed consent; * patients eligible for robotic radical prostatectomy without lymphadenectomy and in the absence of contraindications to undergo the procedure; * patient's ability to understand and willingness to sign a written informed consent indicating that he has understood the purpose and methods of conducting the study and is interested in participating.; * patients able to follow the indications specified in the study protocol; * patients domiciled (even temporarily) \< 150 km away from the institution where the procedure will be performed; * patients domiciled (even temporarily) \< 60 minutes by car from a reference Emergency and Acceptance Department (DEA). Exclusion Criteria: * patients \> 75 years of age; * ASA \> 2; * second simultaneous surgery; * prostate volume \> 80 cc estimated on preoperative imaging (transrectal ultrasound or magnetic resonance imaging); * patients receiving anticoagulants or oral antiplatelet drugs; * other concomitant tumors undergoing treatment; * previous pelvic radiotherapy; * previous surgery for benign prostatic hypertrophy; * patients lacking the digital literacy required to take advantage of telemedicine intervention; * patients who cannot benefit from at least one caregiver; * patients not suitable for a day-surgery approach based on the clinical evaluation of the operating surgeons and anesthetists.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Localized prostate adenocarcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prostate cancer

Contacts and locations

Locations

  • "Regina Elena" National Cancer Institute

    Rome, Rome, 00144, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.